{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:24:47Z","timestamp":1756571087923},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.2515\/therapie\/2015029","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T04:09:52Z","timestamp":1435291792000},"page":"477-484","source":"Crossref","is-referenced-by-count":4,"title":["Les effets ind\u00e9sirables m\u00e9dicamenteux graves et leur \u00e9vitabilit\u00e9 chez des sujets \u00e2g\u00e9s de plus de 65 ans"],"prefix":"10.1016","volume":"70","author":[{"given":"Lukshe","family":"Kanagaratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak Abou","family":"Taam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Heng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"De Boissieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Paule","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Trenque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2015029_bb1065","unstructured":"Insee mobile - Tableaux de l\u2019\u00e9conomie fran\u00e7aise - \u00e9dition 2013. http:\/\/www.insee.fr\/fr\/mobile\/etudes\/document.asp?reg_id=0&id=3806 Consult\u00e9 le 23 avril 2015."},{"issue":"6","key":"10.2515\/therapie\/2015029_bb1070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/092986710790416326","article-title":"Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions","volume":"17","author":"Corsonello","year":"2010","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.2515\/therapie\/2015029_bb1075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejim.2014.10.001","article-title":"Understanding adverse drug reactions in older adults through drug-drug interactions","volume":"25","author":"Marengoni","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.2515\/therapie\/2015029_bb1080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.archger.2004.05.005","article-title":"Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population","volume":"40","author":"Caama\u00f1o","year":"2005","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"10.2515\/therapie\/2015029_bb1085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/00002512-200522090-00005","article-title":"Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause","volume":"22","author":"Passarelli","year":"2005","journal-title":"Drugs Aging"},{"issue":"5","key":"10.2515\/therapie\/2015029_bb1090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.revmed.2009.01.010","article-title":"Adverse drug events in hospitalized elderly patients in a geriatric medicine unit: study of prevalence and risk factors","volume":"30","author":"Cecile","year":"2009","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.2515\/therapie\/2015029_bb1095","first-page":"259","article-title":"Prescription to elderly patients: reducing underuse and adverse drug reactions and improving adherence","volume":"191","author":"Legrain","year":"2007","journal-title":"Bull Acad Natl Med"},{"key":"10.2515\/therapie\/2015029_bb1100","series-title":"Medicines: safety of medecines-adverse drug reactions","author":"World Health Organization","year":"2008"},{"issue":"11","key":"10.2515\/therapie\/2015029_bb1105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-114-11-956","article-title":"The ambiguous relation between aging and adverse drug reactions","volume":"114","author":"Gurwitz","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie\/2015029_bb1110","unstructured":"Official Journal of the European Union. Directive 2010\/84\/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001\/83\/EC on the Community code relating to medicinal products for human useText with EEA relevance. http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN:PDF Consult\u00e9 le 23 avril 2015 (26 pages)"},{"key":"10.2515\/therapie\/2015029_bb1115","unstructured":"European Medicines Agency - Pharmacovigilance - Good pharmacovigilance practices. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/document_listing\/document_listing_000345.jsp#section2 Consult\u00e9 le 23 avril 2015."},{"issue":"2","key":"10.2515\/therapie\/2015029_bb1120","first-page":"109","volume":"20","author":"Brown","year":"1999","journal-title":"The medical dictionary for regulatory activities (MedDRA) Drug Saf"},{"key":"10.2515\/therapie\/2015029_bb1125","unstructured":"WHOCC - ATC\/DDD Index. http:\/\/www.whocc.no\/atc_ddd_index\/ Consult\u00e9 le 23 avril 2015."},{"key":"10.2515\/therapie\/2015029_bb1130","unstructured":"Interactions m\u00e9dicamenteuses - ANSM : Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. http:\/\/ansm.sante.fr\/Dossiers-thematiques\/Interactions-medicamenteuses\/Interactions-medicamenteuses\/(offset)\/0 Consult\u00e9 le 23 avril 2015."},{"issue":"1","key":"10.2515\/therapie\/2015029_bb1135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2515\/therapie:2005005","article-title":"Validation d\u2019une \u00e9chelle de mesure: exemple de l\u2019\u00e9chelle fran\u00e7aise d\u2019\u00e9vitabilit\u00e9 des effets ind\u00e9sirables m\u00e9dicamenteux","volume":"60","author":"Olivier","year":"2005","journal-title":"Therapie"},{"issue":"14","key":"10.2515\/therapie\/2015029_bb1140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00002018-200225140-00005","article-title":"Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department","volume":"25","author":"Olivier","year":"2002","journal-title":"Drug Saf"},{"issue":"7241","key":"10.2515\/therapie\/2015029_bb1145","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","article-title":"Admissions to hospital caused by adverse drug reactions: cross sectional incidence study","volume":"320","author":"Pouyanne","year":"2000","journal-title":"BMJ"},{"issue":"24","key":"10.2515\/therapie\/2015029_bb1150","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"issue":"9","key":"10.2515\/therapie\/2015029_bb1155","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJMc1112874","article-title":"Bleeding risk with dabigatran in the frail elderly","volume":"366","author":"Harper","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.2515\/therapie\/2015029_bb1160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/fcp.12088","article-title":"Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study","volume":"29","author":"B\u00e9nard-Laribi\u00e8re","year":"2015","journal-title":"Fundam Clin Pharmacol Feb"},{"issue":"9","key":"10.2515\/therapie\/2015029_bb1165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.2515\/therapie\/2015029_bb1170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/europace\/eut083","article-title":"European Heart Rhythm Association. European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation","volume":"15","author":"Heidbuchel","year":"2013","journal-title":"Europace"},{"key":"10.2515\/therapie\/2015029_bb1175","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 - Point sur l\u2019utilisation des nouveaux anticoagulants oraux. http:\/\/www.has-sante.fr\/portail\/jcms\/c_1700943\/fr\/point-sur-lutilisation-des-nouveaux-anticoagulants-oraux Consult\u00e9 le 23 avril 2015."},{"key":"10.2515\/therapie\/2015029_bb1180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DHPS.S29287","article-title":"Adverse drug reactions in older patients: an Italian observational prospective hospital study","volume":"4","author":"Conforti","year":"2012","journal-title":"Drug Healthc Patient Saf Jul"},{"issue":"8","key":"10.2515\/therapie\/2015029_bb1185","first-page":"669","article-title":"Adverse drug reactions in a population of hospitalized very elderly patients","volume":"29","author":"Tangiisuran","year":"2012","journal-title":"Drugs Aging Aug"},{"issue":"6","key":"10.2515\/therapie\/2015029_bb1190","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"issue":"4","key":"10.2515\/therapie\/2015029_bb1195","first-page":"365","article-title":"Assessment of preventable iatrogenic drug therapy: methodology. Round Table No 2 at Giens XIII","volume":"53","author":"Imbs","year":"1998","journal-title":"Therapie"},{"issue":"18","key":"10.2515\/therapie\/2015029_bb1200","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/ajhp\/59.18.1742","article-title":"Identifying clinically significant preventable adverse drug events through a hospital\u2019s database of adverse drug reaction reports","volume":"59","author":"Winterstein","year":"2002","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.2515\/therapie\/2015029_bb1205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","article-title":"Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention","volume":"228","author":"Hallas","year":"1990","journal-title":"J Intern Med"},{"issue":"6","key":"10.2515\/therapie\/2015029_bb1210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","article-title":"Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients","volume":"31","author":"Franceschi","year":"2008","journal-title":"Drug Saf"},{"issue":"1","key":"10.2515\/therapie\/2015029_bb1215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/11539290-000000000-00000","article-title":"Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis","volume":"34","author":"Kunac","year":"2011","journal-title":"Drug Saf"},{"issue":"8","key":"10.2515\/therapie\/2015029_bb1220","first-page":"669","article-title":"Adverse drug reactions in a population of hospitalized very elderly patients","volume":"29","author":"Tangiisuran","year":"2012","journal-title":"Drugs Aging"},{"issue":"6","key":"10.2515\/therapie\/2015029_bb1225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002512-200926060-00004","article-title":"Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey","volume":"26","author":"Olivier","year":"2009","journal-title":"Drugs Aging"},{"issue":"6","key":"10.2515\/therapie\/2015029_bb1230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.1351","article-title":"Hospitalisations and emergency department visits due to drug-drug interactions: a literature review","volume":"16","author":"Becker","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.2515\/therapie\/2015029_bb1235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","article-title":"Medication non-adherence among elderly patients newly discharged and receiving polypharmacy","volume":"31","author":"Pasina","year":"2014","journal-title":"Drugs Aging"},{"issue":"11","key":"10.2515\/therapie\/2015029_bb1240","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/jgs.12504","article-title":"Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications","volume":"61","author":"Kanaan","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"35","key":"10.2515\/therapie\/2015029_bb1245","first-page":"21","article-title":"Existe-t-il un sur-risque d\u2019accidents m\u00e9dicamenteux chez les sujets \u00e2g\u00e9s atteints de troubles cognitifs?","volume":"6","author":"Granjon","year":"2006","journal-title":"NPG"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716310903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716310903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:02:21Z","timestamp":1554278541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716310903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0040595716310903"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015029","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}